Neurol. pro Praxi, 2005; 6: 311-314

Testování v neurorehabilitaci

MUDr. Eva Vaňásková, Ph.D.
Rehabilitační klinika FN, Hradec Králové

V neurorehabilitaci je testování stavu nemocných nezbytnou součástí stanovení léčebného postupu a hodnocení efektivity terapie. Umožňuje kromě popisu postižení hodnotit klinickou změnu, srovnávat úspěšnost různých léčebných postupů na úrovni evidence based medicine. Předkládáme přehled základních funkčních testů, které jsou vhodné pro klinickou praxi pro hodnocení velikosti poruchy (impairment), aktivity (activity) a participace (participation) v rámci nové mezinárodní klasifikace (WHO).

Keywords: Klíčová slova: neurorehabilitace, testování, porucha, aktivita, participace.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vaňásková E. Testování v neurorehabilitaci. Neurol. praxi. 2005;6(6):311-314.
Download citation

References

  1. Baatile J, Langbeein WE, Weaver F. Effect of exercise on perceived quality of life of individuals with Parkinson´s diasease. Journal of Rehabilitation Research and Development 2000; 37(5): 529-534. Go to PubMed...
  2. Deutsch A, Fiedler RC, Granger CV, Russel CF. The Uniform Data System for Medical Rehabilitation report of patients discharged from comprehensive medical rehabilitation programs in 1999. Am J Phys Med Rehabil 2002; 81: 133-142. Go to original source... Go to PubMed...
  3. European Organisation for Research and Treatment of Cancer (EORTC) Dostupný na WWW: http://www.eortc.be [cit. 2003-11-08].
  4. Guide for the Uniform Data Set for Medical Rehabilitation, Version 5.1 Buffalo, State University of New York at Buffalo, 1997.
  5. Gúth A a kol. Vyšetrovacie metodiky v rehabilitácii pre fyzioterapeutov. Bratislava: Liečreh, 2004. 400s.
  6. International Classification of Functioning, Disability and Health (WHO ICF). Dostupné na WWW: http://www3.who.int/icf/ [cit. 2003-11-08].
  7. Kaňovský P, Sobotka M, Rektor I. Unifikovaná hodnotící stupnice Parkinsonovy choroby. Čes a Slov Neurol Neurochir 1994; 57/90(5): 220-223.
  8. Karnofsky DA, Abelmann WH, Ceraver LF, et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948; 1: 634-656. Go to original source...
  9. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452. Go to original source... Go to PubMed...
  10. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 14: 61-65. Go to original source...
  11. Opavský J. Neurologické vyšetření v rehabilitaci pro fyzioterapeuty. Olomouc: Vydavatelství Univerzity Palackého, 2003. 91s.
  12. QualityMetric Incorporated Products - SF-36. Dostupný na WWW: http://www.qualitymetric.com [cit. 2005-05-10].
  13. Richards SH, Peters TJ, Coast J, Gunnell DJ. Inter-rater reliability of the Barthel ADL Index: how does a researcher compare to a nurse? Clinical Rehabilitation 2000; 13: 72-78. Go to original source... Go to PubMed...
  14. Růžička, E., Roth, J., Kaňovský, P. et al.: Parkinsonova nemoc a parkinsonské syndromy. Extrapyramidová onemocnění I. Praha: Galén; 2000. 65s.
  15. Unified Parkinson Disease Rating Scale (UPDRS) Dostupný na WWW: http://www.zarcrom.com/users/alzheimers/odem/pd-02a.html [cit. 2005-05-10].
  16. Vaňásková, E. Testování v rehabilitační praxi - cévní mozkové příhody. Skripta. NCO NZO v Brně, 2004. 65s.
  17. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Medical Care 1992; 30(6): 473-483. Go to original source...
  18. Young T, de Haes H, Curran D, Fayers P, Brandberg Y et al. Guidelines for Assesing Quality of Life in EORTC Clinical Trials. EORTC quality of life study group. Brussels. 1999.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.